Skip to main content
SpringerLink
Log in

Eclampsia

  • Chapter
  • First Online:
Management and Therapy of Late Pregnancy Complications

Abstract

Eclampsia is defined as the development of convulsions or unexplained coma during pregnancy or postpartum with signs and symptoms of preeclampsia [107]. In eclampsia the occurrence of the seizures cannot be attributed to causes other than preeclampsia. Despite advances in detection and management, preeclampsia/eclampsia remains a common cause of maternal morbidity and mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Aagaard-Tillery KM, Belfort MA (2005) Eclampsia: morbidity, mortality and management. Clin Obstet Gynecol 48(1):12–23

    Article  PubMed  Google Scholar 

  2. Adelusi B, Ojengbede OA (1986) Reproductive performance after eclampsia. Int J Gynaecol Obstet 24:183–189

    Article  CAS  PubMed  Google Scholar 

  3. Altman D, Carroli G, Duley L et al (2002) Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 359:1877–1890

    Article  PubMed  Google Scholar 

  4. American College of Obstetricians and Gynecologists: Obstetrics analgesia and anesthesia (2002). Practice bulletin, No 36

    Google Scholar 

  5. Andersgaard AB, Herbst A, Johansen M et al (2006) Eclampsia in Scandinavia: incidence, substandard care, and potentially preventable cases. Acta Obstet Gynecol Scand 85:929–936

    Article  PubMed  Google Scholar 

  6. Aukes AM, de Groot JC, Aarnoudse JG et al (2009) Brain lesions several years after eclampsia. Am J Obstet Gynecol 200(504):e1–e5

    Google Scholar 

  7. Aukes AM, De Groot JC, Wiegman MJ et al (2012) Long-term cerebral imaging after pre-eclampsia. BJOG 119:1117–1122

    Article  CAS  PubMed  Google Scholar 

  8. Barton JR, Hiett AK, Conover WB (1990) The use of nifedipine during the postpartum period in patients with severe preeclampsia. Am J Obstet Gynecol 162:788–792

    Article  CAS  PubMed  Google Scholar 

  9. Belfort MA, Tooke-Miller C, Allen J et al (2001) Changes in flow velocity, resistance indices, and cerebral perfusion pressure in the maternal middle cerebral artery distribution during normal pregnancy. Acta Obstet Gynecol Scand 80:104–112

    CAS  PubMed  Google Scholar 

  10. Belfort MA, Anthony J, Saade GR et al (2003) A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med 348:304–311

    Article  CAS  PubMed  Google Scholar 

  11. Belfort MA, Grunewald C, Saade GR et al (1999) Preeclampsia may cause both overperfusion and underperfusion of the brain. Acta Obstet Gynecol Scand 78:586–591

    Article  CAS  PubMed  Google Scholar 

  12. Belfort MA, Saade GR, Grunewald C et al (1999) Effects of blood pressure on orbital and middle cerebral artery resistances in healthy pregnant women and women with preeclampsia. Am J Obstet Gynecol 180:601–607

    Article  CAS  PubMed  Google Scholar 

  13. Belfort MA, Varner MW, Dizon-Townson DS et al (2002) Cerebral perfusion pressure, and not cerebral blood flow, may be the critical determinant of intracranial injury in preeclampsia: a new hypothesis. Am J Obstet Gynecol 187:626–634

    Article  PubMed  Google Scholar 

  14. Berhan Y, Berhan A (2015) Should magnesium sulfate be administered to women with mild pre-eclampsia? A systematic review of published reports on eclampsia. J Obstet Gynaecol Res 41(6):831–842

    Article  CAS  PubMed  Google Scholar 

  15. Bhattacharya S, Prescott GJ, Iversen L et al (2012) Hypertensive disorders of pregnancy and future health and mortality: a record linkage study. Pregnancy Hypertens 2:1–7

    CAS  PubMed  Google Scholar 

  16. Bossuyt PM (2012) Clinical validity: defining biomarker performance. Scand J Clin Lab Investig Suppl 24:246–252

    Google Scholar 

  17. Brewer J, Owens MY, Wallace K et al (2013) Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia. Am J Obstet Gynecol 208(6):468. e1–e6

    Google Scholar 

  18. Brussé IA, Peters NC, Steegers EA et al (2012) Electroencephalography during normotensive and hypertensive pregnancy: a systematic review. Obstet Gynecol Surv 65(12):794–803

    Article  Google Scholar 

  19. Bryans CI, Southerland WL, Zuspan FP (1963) Eclampsia: a follow-up study of eclamptic women. Obstet Gynecol 21:701–707

    PubMed  Google Scholar 

  20. Campbell DM, Templeton AA (1980) Is eclampsia preventable? In: Bonnar J, MacGillivray I, Symonds EM (eds) Pregnancy hypertension, proceedings. University Park Press, Baltimore, pp 483–488

    Chapter  Google Scholar 

  21. Caritis S, Sibai B, Hauth J et al (1998) Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 338:701–705

    Article  CAS  PubMed  Google Scholar 

  22. Cerdeira AS, Karumanchi SA (2011) Biomarkers in preeclampsia. In: Edelstein CL (ed) Biomarkers of kidney disease, 1st edn. Academic/Elsevier, Amsterdam/Boston, pp 385–426

    Chapter  Google Scholar 

  23. Chames MC, Livingston JC, Invester TS et al (2002) Late postpartum eclampsia: a preventable disease? Am J Obstet Gynecol 186:1174–1177

    Article  PubMed  Google Scholar 

  24. Chien D, Kwong KK, Gress DR et al (1992) MR diffusion imaging of cerebral infarctions in humans. Am J Neuroradiol 13:1097–1102

    CAS  PubMed  Google Scholar 

  25. Cipolla MJ, Bishop N, Chan SL (2012) Effect of pregnancy on autoregulation of cerebral blood flow in anterior versus posterior cerebrum. Hypertension 60:705–711

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Clark SL, Divon MY, Phelan JP (1985) Preeclampsia/eclampsia: hemodynamic and neurologic correlations. Obstet Gynecol 66:337–340

    CAS  PubMed  Google Scholar 

  27. Clark SL, Horenstein JM, Phelan JP et al (1985) Experience with the pulmonary artery catheter in obstetrics and gynecology. Am J Obstet Gynecol 152:374–378

    Article  CAS  PubMed  Google Scholar 

  28. CLASP (1994) A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 343:619–629

    Article  Google Scholar 

  29. Coetzee EJ, Dommisse J, Anthony J (1985) A randomized controlled trial of intravenous magnesium soleplate versus placebo in the management of women with severe preeclampsia. Br J Obstet Gynaecol 105:300–303

    Article  Google Scholar 

  30. Coevoet B, Leuliet J, Comoy E et al (1980) Labetalol in the treatment of hypertension of pregnancy: clinical effects and interactions with plasma renin and dopamine betahydroxylase activities, and with plasma concentrations of catecholamine. Kidney Int 17:701

    Google Scholar 

  31. Committee Opinion No. 623 (2015) Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Committee on Obstetric Practice. Obstet Gynecol 125(2):521–525

    Article  Google Scholar 

  32. Cotton DB, Lee W, Huhta JC, Dorman KF (1988) Hemodynamic profile of severe pregnancy – induced hypertension. Am J Obstet Gynecol 158:523–529

    Article  CAS  PubMed  Google Scholar 

  33. Cunningham FG, Twickler DM (2000) Cerebral edema complicating eclampsia. Am J Obstet Gynecol 182:94–100

    Article  CAS  PubMed  Google Scholar 

  34. Dahmus MA, Barton JR, Sibai BM (1992) Cerebral imaging in eclampsia: magnetic resonance imaging versus computed tomography. Am J Obstet Gynecol 167:935–941

    Article  CAS  PubMed  Google Scholar 

  35. Dildy GA, Cotton DB (1988–1989) Hemodynamic changes in pregnancy and pregnancy complicated by hypertension. Acute Care 14–15:26–46. Pubmed (PMID:3155032)

    Google Scholar 

  36. Dildy GA, Cotton DB (1991) Management of severe preeclampsia and eclampsia. Crit Care Clin 7:829–850

    PubMed  Google Scholar 

  37. Douglas KA, Redman CW (1994) Eclampsia in the United Kingdom. BMJ 309:1395–1400

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Duckitt K, Harrington D (2005) Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330:565

    Article  PubMed  PubMed Central  Google Scholar 

  39. Ducros A (2012) Reversible cerebral vasoconstriction syndrome. Lancet Neurol 11:906–917

    Article  PubMed  Google Scholar 

  40. Duley L, Henderson-Smart DJ, Meher S (2005) Altered dietary salt for preventing pre-eclampsia, and its complications. Cochrane Database Syst Rev Issue (4). Art. No.: CD005548

    Google Scholar 

  41. Duley L (2009) The global impact of pre-eclampsia and eclampsia. Semin Perinatol 33:130–137

    Article  PubMed  Google Scholar 

  42. Easton JD (1998) Severe preeclampsia/eclampsia: hypertensive encephalopathy of pregnancy? Cerebrovasc Dis 8:53–58

    Article  CAS  PubMed  Google Scholar 

  43. El-Nafaty AU, Melah GS, Massa AA et al (2004) The analysis of eclamptic morbidity and mortality in the Specialist Hospital Gombe, Nigeria. J Obstet Gynaecol 24:142–147

    Article  CAS  PubMed  Google Scholar 

  44. Euser AG, Cipolla MJ (2007) Cerebral blood flow autoregulation and edema formation during pregnancy in anesthetized rats. Hypertension 49:334–340

    Article  CAS  PubMed  Google Scholar 

  45. Herling IM (1984) Intravenous nitroglycerin: clinical pharmacology and therapeutic considerations. Am Heart J 108:141–149

    Article  CAS  PubMed  Google Scholar 

  46. Hinchey J, Chaves C, Appignani B et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494–500

    Article  CAS  PubMed  Google Scholar 

  47. Hofmeyr GJ, Lawrie TA, Atallah ÁN et al (2010) Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev (8). Art. No.: CD001059

    Google Scholar 

  48. Hogg B, Hauth JC, Caritis SN et al (1999) Safety of labor epidural anesthesia for women with severe hypertensive disease. Am J Obstet Gynecol 181:1096–1101

    Article  CAS  PubMed  Google Scholar 

  49. Hypertension in pregnancy (2013) Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 122(5):1122–1131

    Article  Google Scholar 

  50. Katz VL, Farmer R, Kuller J (2000) Preeclampsia into eclampsia: toward a new paradigm. Am J Obstet Gynecol 182:1389–1396

    Article  CAS  PubMed  Google Scholar 

  51. Knight M (2007) Eclampsia in the United Kingdom 2005. BJOG 114:1072–1078

    Article  CAS  PubMed  Google Scholar 

  52. Koch-Weser J (1976) Hydralazine. N Engl J Med 295:320–323

    Article  CAS  PubMed  Google Scholar 

  53. Lamy C, Oppenheim C, Meder JF et al (2004) Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 14:89–96

    Article  CAS  PubMed  Google Scholar 

  54. Lavies NG, Meiklejohn BH, May AE et al (1989) Hypertensive and catecholamine response to tracheal intubation in patients with pregnancy-induced hypertension. Br J Anaesth 63:429–434

    Article  CAS  PubMed  Google Scholar 

  55. Leitch CR, Cameron AD, Walker JJ (1997) The changing pattern of eclampsia over a 60-year period. Br J Obstet Gynaecol 104:917–922

    Article  CAS  PubMed  Google Scholar 

  56. Lincoln J (1995) Innervation of cerebral arteries by nerves containing 5-hydroxytryptamine and noradrenaline. Pharmacol Ther 68:473–501

    Article  CAS  PubMed  Google Scholar 

  57. Liu S, Joseph KS, Bartholomew S et al (2010) Temporal trends and regional variations in severe maternal morbidity in Canada, 2003 to 2007. J Obstet Gynaecol Can 32:847–855

    Article  CAS  PubMed  Google Scholar 

  58. Liu S, Joseph KS, Liston RM, Bartholomew S et al (2011) Maternal Health Study Group of Canadian perinatal surveillance system (Public Health Agency of Canada). Incidence, risk factors, and associated complications of eclampsia. Obstet Gynecol 118(5):987–994

    Article  PubMed  Google Scholar 

  59. Lo'pez-LIera M (1992) Main clinical types and subtypes of eclampsia. Am J Obstet Gynecol 166:4–9

    Article  Google Scholar 

  60. Lo'pez-LIera M (1993) Recurrent eclampsia; clinical data, morbidity and pathogenic considerations. Eur J Obstet Gynecol Reprod Biol 50:39–45

    Article  Google Scholar 

  61. Loureiro R, Leite CC, Kahhale S et al (2003) Diffusion imaging may predict reversible brain lesions in eclampsia and severe preeclampsia: initial experience. Am J Obstet Gynecol 189:1350–1355

    Article  PubMed  Google Scholar 

  62. Lubarsky SL, Barton JR, Friedman SA et al (1994) Late postpartum eclampsia revisited. Obstet Gynecol 83:502–505

    Article  CAS  PubMed  Google Scholar 

  63. Lucas MJ, Leveno KJ, Cunningham FG (1995) A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 333:210–215

    Article  Google Scholar 

  64. Lund-Johnson P (1983) Short- and long- term (six year) hemodynamic effects of labetalol in essential hypertension. Am J Med 75:24–31

    Article  Google Scholar 

  65. Lunell NO, Hjemdahl P, Fredholm BB et al (1981) Circulatory and metabolic effects of a combined α – and β – adrenoceptor blocker (labetalol) in hypertension of pregnancy. Br J Clin Pharmacol 12:345–348

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Lykke JA, Langhoff-Roos J, Lockwood CJ et al (2010) Mortality of mothers from cardiovascular and non-cardiovascular causes following pregnancy complications in first delivery. Paediatr Perinat Epidemiol 24:323–330

    Article  PubMed  Google Scholar 

  67. Lyons G (2008) Saving mothers’ lives: confidential enquiry into maternal and child health 2003–5. Int J Obstet Anesth 17:103–105

    Article  PubMed  Google Scholar 

  68. Mabie WC, Gonzalez AR, Sibai BM et al (1987) A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol 70:328–333

    CAS  PubMed  Google Scholar 

  69. MacKay AP, Berg CJ, Atrash HK (2001) Pregnancy related mortality from preeclampsia and eclampsia. Obstet Gynecol 97:533–538

    CAS  PubMed  Google Scholar 

  70. Magee LA, Miremadi S, Li J et al (2005) Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol 193:153–163

    Article  CAS  PubMed  Google Scholar 

  71. Magee LA, Ornstein MP, VonDadelszen P (1999) Fortnightly review: management of hypertension in pregnancy. BMJ 318:1332–1336

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Magpie Trial Collaborative Group (2002) Do women with preeclampsia, and their babies, benefit from magnesium sulfate? The Magpie Trial: a randomized placebo-controlled trial. Lancet 359:1877–1890

    Article  Google Scholar 

  73. Martin JN Jr, Thigpen BD et al (2005) Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 105:246–254

    Article  PubMed  Google Scholar 

  74. Mattar F, Sibai BM (2000) Eclampsia. VIII. Risk factors for maternal morbidity. Am J Obstet Gynecol 82:307–312

    Article  Google Scholar 

  75. Meher S, Duley L (2006) Rest during pregnancy for preventing preeclampsia and its complications in women with normal blood pressure. Cochrane Database Syst Rev (2). Art. No.: CD005939

    Google Scholar 

  76. Michael CA (1979) Use of labetalol in the treatment of severe hypertension during pregnancy. Br J Clin Pharmacol 8:211S–215S

    Article  CAS  PubMed Central  Google Scholar 

  77. Mongraw-Chaffin ML, Cirillo PM, Cohn BA (2010) Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension 56:166–171

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Morriss MC, Twickler DM, Hatab MR et al (1997) Cerebral blood flow and cranial magnetic resonance imaging in eclampsia and severe preeclampsia. Obstet Gynecol 89:561–568

    Article  CAS  PubMed  Google Scholar 

  79. National Heart, Lung, and Blood Institute (2004) The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure, NIH Publication No. 04-5230. NHLBI, Bethesda

    Google Scholar 

  80. National High Blood Pressure Education Program (2000) Working Group report on high blood pressure in pregnancy. Am J Obstet Gynecol 183:51

    Google Scholar 

  81. Newman RB, Eddly GL (1988) Association of eclampsia and hydatidiform mole: case report and review of the literature. Obstet Gynecol Surv 43:185–190

    Article  CAS  PubMed  Google Scholar 

  82. Nilsson PM, Li X, Sundquist J et al (2009) Maternal cardiovascular disease risk in relation to the number of offspring born small for gestational age: national, multi-generational study of 2.7 million births. Acta Paediatr 98:985–989

    Article  PubMed  Google Scholar 

  83. Paauw ND, Luijken K, Franx A et al (2016) Long-term renal and cardiovascular risk after preeclampsia: towards screening and prevention. Clin Sci (Lond) 130(4):239–246

    Article  CAS  Google Scholar 

  84. Pritchard JA, Cunningham FG, Pritchard SA (1984) The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases. Am J Obstet Gynecol 148:951–963

    Article  CAS  PubMed  Google Scholar 

  85. Raheem IA, Saaid R, Omar SZ et al (2012) Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial. BJOG 119:78–85

    Article  CAS  PubMed  Google Scholar 

  86. Rezaei Z, Sharbaf FR, Pourmojieb M et al (2011) Comparison of the efficacy of nifedipine and hydralazine in hypertensive crisis in pregnancy. Acta Med Iran 49:701–706

    CAS  PubMed  Google Scholar 

  87. Royal College of Obstetrician and Gynecologists (2006) The management of severe preeclampsia. RCIG Guideline 10A:1

    Google Scholar 

  88. Rugarn O, Carling Moen S, Berg G (2004) Eclampsia at a tertiary hospital 1973 to 1999. Acta Obstet Gynecol Scand 83:240–245

    Article  PubMed  Google Scholar 

  89. Rumbold A, Duley L, Crowther CA et al (2008) Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev (1). Art. No.: CD004227

    Google Scholar 

  90. Rumbold AR, Crowther CA, Haslam RR et al (2006) Vitamins C and E and the risks of preeclampsia and perinatal complications. ACTS Study Group. N Engl J Med 354:1796–1806

    Article  CAS  PubMed  Google Scholar 

  91. Schiff E, Peleg E, Goldenberg M et al (1989) The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 321:351–356

    Article  CAS  PubMed  Google Scholar 

  92. Schwartz RB, Feske SK, Polak JF et al (2000) Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology 217:371–376

    Article  CAS  PubMed  Google Scholar 

  93. Sciscione AC, Ivester T, Largoza M et al (2003) Acute pulmonary edema in pregnancy. Obstet Gynecol 101:511–515

    PubMed  Google Scholar 

  94. Shah AK, Rajamani K, Whitty JE (2008) Eclampsia: a neurologic perspective. J Neurol Sci 271:158–167

    Article  CAS  PubMed  Google Scholar 

  95. Sibai BM, Abdella TN, Spinnato JA (1986) Eclampsia. V. The incidence of nonpreventable eclampsia. Am J Obstet Gynecol 154:581–586

    Article  CAS  PubMed  Google Scholar 

  96. Sibai BM, Anderson GD, Abdella TN et al (1983) Eclampsia. III. Neonatal outcome, growth, and development. Am J Obstet Gynecol 146:307–315

    Article  CAS  PubMed  Google Scholar 

  97. Sibai BM, El-Nazer A, Gonzalez-Ruiz A (1986) Severe preeclampsia- eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 155:1011–1016

    Article  CAS  PubMed  Google Scholar 

  98. Sibai BM, Gordon T, Thom E et al (1995) Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. Am J Obstet Gynecol 172:642–648

    Article  CAS  PubMed  Google Scholar 

  99. Sibai BM, Graham JM, McCubbin JH (1984) A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia. Am J Obstet Gynecol 150:728–733

    Article  CAS  PubMed  Google Scholar 

  100. Sibai BM, Makie WC, Harvey CJ et al (1987) Pulmonary edema in severe preeclampsia-eclampsia: analysis of 37 consecutive cases. Am J Obstet Gynecol 156:1174–1179

    Article  CAS  PubMed  Google Scholar 

  101. Sibai BM, Sarinoglu C, Mercer BM (1992) Eclampsia. VII. Pregnancy outcome after eclampsia and long-term prognosis. Am J Obstet Gynecol 166:1757–1763

    Article  CAS  PubMed  Google Scholar 

  102. Sibai BM, Stella CL (2009) Diagnosis and management of atypical preeclampsia-eclampsia. Am J Obstet Gynecol 200(481):e1–481e6

    Google Scholar 

  103. Sibai BM (2003) Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102:181–192

    PubMed  Google Scholar 

  104. Sibai BM (1990) Eclampsia. VI. Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 163:1049–1055

    Article  CAS  PubMed  Google Scholar 

  105. Sibai BM (2012) Hypertension. In: Gabbe SG, Niebyl JR, Simpson JL (eds) Obstetrics: normal and problem pregnancies, 6th edn. Churchill Livingstone, New York

    Google Scholar 

  106. Sibai BM (2004) Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials. Am J Obstet Gynecol 190:1520–1526

    Article  CAS  PubMed  Google Scholar 

  107. Sibai BM (2005) Diagnosis, differential diagnosis, and management of eclampsia. Obstet Gynecol 105:402–410

    Article  PubMed  Google Scholar 

  108. Spinnato JA, Sibai BM, Anderson GD (1986) Fetal distress after hydralazine therapy for severe pregnancy – induced hypertension. South Med J 79:559–562

    Article  CAS  PubMed  Google Scholar 

  109. Taslimi MM, Harbin AR, Gonzalez-Ruiz A (1991) Captopril in severe preeclampsia. J Natl Med Assoc 83:721–723

    CAS  PubMed  PubMed Central  Google Scholar 

  110. The Eclampsia Trial Collaborative Group (1995) Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet 345:1455–1463

    Article  Google Scholar 

  111. Trommer BL, Homer D, Mikhael MA (1988) Cerebral vasospasm and eclampsia. Stroke 19:326–329

    Article  CAS  PubMed  Google Scholar 

  112. Van den Veyver IB, Belfort MA, Rowe TF et al (1994) Cerebral vasospasm in eclampsia: transcranial Doppler ultrasound findings. J Matern Fetal Med 3:9–13

    Article  Google Scholar 

  113. Van Veer TR, Panerai RB, Haeri S et al (2013) Cerebral autoregulation in normal pregnancy and preeclampsia. Obstet Gynecol 122(5):1064–1069

    Article  Google Scholar 

  114. Vermillion ST, Scardo JA, Newman RB (1999) A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy. Am J Obstet Gynecol 181:858–861

    Article  CAS  PubMed  Google Scholar 

  115. Wallace DH, Leveno KJ, Cunningham FG et al (1995) randomized comparison general and regional anesthesia for cesarean delivery in pregnancies complicated by severe preeclampsia. Obstet Gynecol 86:193–199

    Article  CAS  PubMed  Google Scholar 

  116. Wallenburg HC, Dekker GA, Makovitz JW et al (1986) Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet 1:1–3

    Article  CAS  PubMed  Google Scholar 

  117. Wallis AB, Saftlas AF, Hsia J et al (2008) Secular trends in the rates of pre-eclampsia, eclampsia, and gestational hypertension, United States, 1987–2004. Am J Hypertens 21:521–526

    Article  PubMed  Google Scholar 

  118. Wasserstrum N, Cotton DB (1986) Hemodynamic monitoring in severe pregnancy- induced hypertension. Clin Perinatol 13:781–799

    CAS  PubMed  Google Scholar 

  119. Wiegman MJ, Zeeman GG, Aukes AM et al (2014) Regional distribution of cerebral white matter lesions years after preeclampsia and eclampsia. Obstet Gynecol 123:790–795

    Article  PubMed  Google Scholar 

  120. Witlin AG, Sibai BM (1998) Magnesium sulfate in preeclampsia and eclampsia. Obstet Gynecol 92:883–889

    CAS  PubMed  Google Scholar 

  121. Zeeman GG, Cunningham FG, Pitchard JA (2009) The magnitude of hemoconcentration in eclampsia. Hypertens Pregnancy 28:127–137

    Article  PubMed  Google Scholar 

  122. Zeeman GG, Fleckenstein JL, Twickler DM et al (2004) Cerebral infarction in eclampsia. Am J Obstet Gynecol 190:714–720

    Article  PubMed  Google Scholar 

  123. Zeeman GG, Hatab MR, Twickler DM (2003) Maternal cerebral blood flow changes in pregnancy. Am J Obstet Gynecol 189:968–972

    Article  PubMed  Google Scholar 

  124. Zwart JJ, Richters A, Ory F et al (2008) Eclampsia in the Netherlands. Obstet Gynecol 112:820–827

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Baylor College of Medicine, Texas Children’s Hospital, Houston, TX, USA

    Amir A. Shamshirsaz MD, Nicole Ruddock Hall MD & Michael A. Belfort MD, PhD

  2. Department of Obstetrics and Gynaecology, Santa Maria Hospital, GVM Care and Research, Bari, Italy

    Antonio Malvasi MD

  3. The International Translational Medicine and Biomodelling Research Group, Department of Applied Mathematics, Moscow Institute of Physics and Technology (State University), Moscow, Russia

    Antonio Malvasi MD

  4. Department of Obstetrics and Gynaecology, Division of Experimental Endoscopic Surgery, Imaging, Technology and Minimally Invasive Therapy, Vito Fazzi Hospital, Lecce, Italy

    Andrea Tinelli MD, PhD

  5. Laboratory of Human Physiology, Moscow Institute of Physics and Technology (State University), Dolgoprudny, Moscow Region, Russia

    Andrea Tinelli MD, PhD

Authors
  1. Amir A. Shamshirsaz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicole Ruddock Hall MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonio Malvasi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andrea Tinelli MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael A. Belfort MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael A. Belfort MD, PhD .

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, Santa Maria Hospital, G.V.M. Care and Research, Bari, Italy

    Antonio Malvasi

  2. Department of Obstetrics and Gynecology, Division of Experimental Endoscopic Surgery, Imaging, Technology and Minimally Invasive Therapy, Technology and Minimally Invasive Therapy, Vito Fazzi Hospital, Piazza Muratore, Lecce, Italy

    Andrea Tinelli

  3. Department of Obstetrics and Gynecology, Centre for Perinatal and Reproductive Medicine, Santa Maria della Misericordia University, Hospiatal, Perugia, Italy

    Gian Carlo Di Renzo

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Shamshirsaz, A.A., Hall, N.R., Malvasi, A., Tinelli, A., Belfort, M.A. (2017). Eclampsia. In: Malvasi, A., Tinelli, A., Di Renzo, G. (eds) Management and Therapy of Late Pregnancy Complications. Springer, Cham. https://doi.org/10.1007/978-3-319-48732-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-48732-8_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-48730-4

  • Online ISBN: 978-3-319-48732-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation